Jordan Krall

Jordan Krall is currently working as a Director at MOMA Therapeutics since September 2021. Previously, held positions as Associate Director/Principal Scientist at Servier Pharmaceuticals from April 2021 to September 2021 and at Agios Pharmaceuticals from October 2017 to March 2021. Prior to that, spent time as a Postdoctoral Fellow at Whitehead Institute from September 2009 to September 2017, focusing on Immunologic and Tumor Cell-intrinsic Regulation of Metastasis under mentor Robert A. Weinberg, Ph.D. Jordan holds a Ph.D. in Chemistry and Chemical Biology from Harvard University, MSc in Chemistry from the University of Oxford as a Rhodes Scholar, and a Bachelor’s Degree in Chemistry from Amherst College.